Get more from your baby's cord blood.

Benefits beyond stem cells.

Image
New father and newborn resting peacefully in bed
wave-left-crest-svg wave-left-crest-mob-svg
wave-right-crest-svg

knowledge is power

Unlock Genetic Health Insights

The dream of using DNA insights to help manage health is now a reality. And for families banking cord blood with ViaCord, it’s easier than ever. Accessing genetic health insights early empowers parents and healthcare providers to support a child's health and well-being from the start.

  • Proactive Healthcare
  • Informed Decisions
  • Personalized Treatments

 


 

Image
ViaCord Information Kit
wave-left-crest-svg wave-left-crest-mob-svg
wave-right-crest-svg

How It Works

ViaCord is the only family cord blood bank harnessing the power of cord blood & DNA to help parents unlock valuable genetic health insights. 
 

  • Tests are optional add-ons for families banking cord blood.
  • We isolate a small sample of the collected cord blood for testing.
  • No additional testing required or impact to the stem cells banked. 

Image
DNA Insights using Cord Blood

Additional Test Options

Genetic testing can offer valuable insights into various aspects of health, including predispositions for certain conditions. Cord blood offers a unique and early opportunity to access insights.

boy
For Newborns
Newborn Digestive Health

Genetic insights into predisposition for celiac disease and primary lactose intolerance.

Img
For Newborns
Whole Genome Sequencing

Analysis of 2,500 genes with known associations to childhood onset-conditions and drug sensitivities.

father-resting-with-newborn-in-bed
For Newborns
Newborn DNA Guardian

Preserve a sample of your newborn's pristine DNA for potential future genomic testing.

ViaCord's Newborn Genetic Insights Panel
For Newborns
Genetic Insights Panel

Analysis of 290+ genes associated with childhood-onset conditions.

wave-left-crest-svg wave-left-crest-mob-svg
wave-right-crest-svg

STUDY RESULTS: 1 IN 12 CHILDREN

ViaCord’s Whole Genome Sequencing

A retrospective study published in the Journal of American Medical Association (JAMA) found 1 in 12 apparently healthy newborns who used ViaCord's Whole Genome Sequencing carried genetic findings that could impact their health from an early age. 47% of these findings were associated with health conditions that could benefit from early intervention and medical management.1

Image
ViaCord WGS 1 in 12 Children Finding
Image
ViaCord Information Kit
X
X
X